Saifu Pharmaceutical is a preclinical CRO service provider.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 2, 2022 | Series D | ¥500M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Jianxing Medical Fund | — | Series D |